Business

Licenses CSD500 to Ansell in China

Licenses CSD500 to Ansell in China.

articleFutura Medical PlcDecember 6, 20133/company/futura-medical-plc/news/licenses-csd500-to-ansell-in-china
Licenses CSD500 to Ansell in China

About this update from Futura Medical Plc

[{"type":"text","content":"\n \nRNS Number : 8623U Futura Medical PLC 06 December 2013  \n \n\n\n\n\n\nFor immediate release\n\n\n6 December 2013\n\n\n\n\n \n \nFutura Medical PLC\n(\"Futura\" or the \"Company\")\n \nFutura licenses CSD500 to Ansell in China\n \nFutura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has signed an exclusive licensing agreement with Ansell Limited, a global leader in protection solutions, for the marketing and distribution of CSD500, Futura's novel condom, in China.\n \nAnsell is a leading condom distributor in China including the country's second largest condom brand, Jissbon. The financial details of the agreement with Ansell are not being disclosed although Futura will receive milestone payments and royalties on product sales along with certain minimum performance guarantees.\n \nAnsell and Futura will work together to achieve regulatory approval in China for CSD500.  Futura is currently in dialogue with the relevant Chinese regulatory authorities to identify any further clinical work required prior to the submission of a regulatory dossier for marketing authorisation.\n \nThis agreement with Ansell is in line with Futura's strategy of licensing CSD500 to condom distributors that hold leading positions in specific geographic regions. \n \nThe agreement builds on Futura's existing relationship with Ansell, which already holds worldwide marketing rights to Futura's novel spray for enhanced sexual control, PET500.\n \nPeter Carroll, Ansell's President and General Manager - Sexual Wellness Global Business Unit, said: \"We are very pleased to be strengthening our relationship with Futura by licensing rights to CSD500 in China, a region in which we have a major presence. CSD500 is a highly novel condom which we believe could have significant market potential in China.\" \n \nJames Barder, Futura's Chief Executive, commented: \"We are delighted to sign this exclusive agreement with Ansell for the marketing and distribution of CSD500 in China, where Ansell has a strong market position through its Jissbon brand. China is potentially the world's biggest market for condoms and we therefore look forward to working with Ansell to progress the product to launch.\"\n \n \n \nFor further info...

More updates from Futura Medical Plc